会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHOD FOR THE PRODUCTION OF SPECIFIC INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE, IN PARTICULAR TYPE 1 WITH BASIC NOR-OLEANAN OR NOR-URSAN FRAMEWORKS
    • PROCESS FOR11β-羟基类固醇脱氢酶的特异性抑制剂的制备中,特别是II型1 WITH NOR齐墩果烷OR NOR Ursan BASIC框架
    • WO2008071169A2
    • 2008-06-19
    • PCT/DE2007002218
    • 2007-12-10
    • UKSH SCHLESWIG HOLSTEINBLUM ANDREASMASER EDMUND
    • BLUM ANDREASMASER EDMUND
    • C07J63/00A61K31/56
    • The invention relates to a method for modifying non-specific inhibitors of 11 beta hydroxysteroid dehydrogenase (11 beta HSD) with a basic pentacyclic framework of the oleanan and ursan type, in order to be able to synthesize chemical compounds which inhibit 11 beta hydroxysteroid dehydrogenase and which, preferably, inhibit the substantially specific iso form of 11 beta hydroxysteroid dehydrogenase type 1, and which thus have substantially no inhibiting effect on the iso form of 11 beta hydroxysteroid dehydrogenase type 2 (11 beta HSD2). The invention further relates to novel chemical compounds with basic nor-oleanan or non-ursan frameworks. These inhibitors act as substantially specific inhibitors of 11 beta HSD1 and are thus suitable for the treatment and prevention of diabetes, metabolic syndrome, adiposis, corpulence, overweight, hyperlipoproteinemia, hypoglycemia, hyperinsulinemia, arteriosclerosis, dementia, depressions, osteoporosis, glaucoma, or virus diseases.
    • 本发明涉及一种方法,用于修改所述11β-羟基类固醇脱氢酶(11β-HSD)的与齐墩果烷和乌苏烷型pentacyclischem骨干,这使得能够制造出抑制11β-羟基类固醇脱氢酶和化学化合物的非特异性作用酶抑制剂 优选基本上特定1型抑制11β-羟基类固醇脱氢酶(11β-HSD1)的同种型,而2型包括(11β-HSD2)实质上靠在11β-羟基类固醇脱氢酶的同种型没有抑制活性。 此外,本发明涉及具有去甲齐墩果烷或标准Ursan骨干新化合物。 这些抑制剂充当11β-HSD1是基本上特异性抑制剂,并因此关于治疗和预防某些糖尿病,代谢综合征,肥胖症,肥胖,肥胖症,高脂蛋白血症,高血糖症,高胰岛素血症,动脉粥样硬化,痴呆,抑郁症,Osteroporese,青光眼或病毒疾病的 合适的。